Cardiomedex vs Inotiv

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cardiomedex/inotivco

Category	Cardiomedex	Inotiv
Listed site	cro	cro
Summary	Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.	Inotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.
Services	Cardiovascular & Metabolic Specialty Services In Vivo Efficacy Models Preclinical In Vivo Studies In Vitro Pharmacology Preclinical In Vitro Studies Translational Research	Translational Research In Vitro Pharmacology In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vitro Studies Preclinical In Vivo Studies GLP Toxicology Genetic Toxicology Safety Pharmacology Carcinogenicity Studies Bioanalysis LC-MS Bioanalysis (Small Molecule) Pathology & Histology Services Proteomics Services Genomics & Sequencing Services Specialized & Large-Animal Models Device & Combination Product Services Cardiovascular & Metabolic Specialty Services CNS Specialty Services Oncology Specialty Services Immunology & Inflammation Services
Modalities	Small Molecule	Cell Therapy Gene Therapy
Indications	Cardiovascular Metabolic	Cardiovascular Gastroenterology Infectious Disease Immunology Metabolic Neurology Oncology Respiratory Nephrology
Locations	Headquarters, Toulouse, France	Data not yet provided.
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.